APA (7th ed.) Citation

Steenbrugge, J., Elst, N. V., Demeyere, K., Wever, O. D., Sanders, N. N., Broeck, W. V. D., . . . Meyer, E. (2021). OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer. Nature Portfolio.

Chicago Style (17th ed.) Citation

Steenbrugge, Jonas, Niels Vander Elst, Kristel Demeyere, Olivier De Wever, Niek N. Sanders, Wim Van Den Broeck, Eric Ciamporcero, Timothy Perera, and Evelyne Meyer. OMO-1 Reduces Progression and Enhances Cisplatin Efficacy in a 4T1-based Non-c-MET Addicted Intraductal Mouse Model for Triple-negative Breast Cancer. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Steenbrugge, Jonas, et al. OMO-1 Reduces Progression and Enhances Cisplatin Efficacy in a 4T1-based Non-c-MET Addicted Intraductal Mouse Model for Triple-negative Breast Cancer. Nature Portfolio, 2021.